Pharmaceutical companies have invested billions developing advanced transdermal technologies (iontophoresis, sonophoresis, chemical enhancers, microneedles) specifically because passive patches cannot deliver most drugs
It lightens gradually, but maintenance is needed to sustain results
muciniphila was discovered to improve HFD-induced intestinal hyperpermeability and also affect intestinal barrier function by the way that upregulates the expression of tight junction and closure proteins (Li et al., 2016)
Bianchi-Smiraglia A, Wolff DW, Marston DJ, Deng Z, Han Z, Moparthy S, Wombacher RM, Mussell AL, Shen S, Chen J, Yun DH, OBrien Cox A, Furdui CM, Hurley E, Feltri ML, Qu J, Hollis T, Kengne JBN, Fongang B, Sousa RJ, Kandel ME, Kandel ES, Hahn KM, Nikiforov MA